HealthEquity Stock Gains as Q2 Earnings Beat Estimates, Revenues Up Y/Y

HealthEquity (HQY) delivered strong second-quarter fiscal 2026 results, with adjusted EPS of $1.08 and revenues of $325.8 million both exceeding consensus estimates and growing significantly year-over-year. This performance was driven by robust expansion in Health Savings Accounts (HSAs), which reached 10 million total accounts and $33.1 billion in assets, contributing to substantial gross and operating margin expansion. Shares rose 3.7% after-market as HQY also raised its full-year fiscal 2026 revenue and adjusted EPS guidance, though management noted ongoing labor market pressures are moderating new account openings.

Analysis

HealthEquity, Inc. (HQY) reported a robust second quarter for fiscal 2026, significantly outperforming consensus estimates on both revenue and earnings. Adjusted EPS of $1.08 represented a 25.6% year-over-year increase and a 17.4% beat, while revenue of $325.8 million grew 8.6% year-over-year. The performance was underpinned by strong growth in the company's core Health Savings Account (HSA) business, with total HSA assets climbing 12% to $33.1 billion and total accounts reaching 10 million. The key driver of profitability was substantial margin expansion; the gross margin expanded by 340 basis points to 71.4%, and the operating margin saw a significant 790 basis point improvement to 27.5%. This was achieved through a combination of strong top-line growth, particularly a 15.3% rise in high-margin custodial revenues, and disciplined cost control that resulted in a 1.5% decrease in total operating expenses. Reflecting this momentum, HealthEquity raised its full-year 2026 guidance for both revenue and adjusted EPS, with the new EPS range of $3.74-$3.91 surpassing the current consensus estimate. However, management tempered this positive outlook by acknowledging that a softer labor market, with job growth down 40% year-to-date, is creating a headwind and moderating the pace of new account openings.

Key Decisions for Investors

• Investors should recognize the strong operational execution demonstrated by the significant earnings beat, 790 bps operating margin expansion, and raised full-year guidance, which suggest fundamental strength and effective cost controls.
• It is prudent to monitor macroeconomic labor market indicators, as management explicitly cited softness in job growth as a headwind that is muting the pace of new Health Savings Account (HSA) openings, a key long-term growth driver.
• Consider the company's ability to drive growth through internal initiatives, such as improved member engagement via technology and a 10% YoY increase in higher-value invested HSA accounts, as potential offsets to the weaker employment market.